Evidence map›Paper›PMID 30327713›Full record

ArticleOxidative medicine and cellular longevity2018

Heme Oxygenase-1 May Affect Cell Signalling via Modulation of Ganglioside Composition.

Václav Šmíd, Jakub Šuk, Neli Kachamakova-Trojanowska, Jana Jašprová, Petra Valášková, Alicja Józkowicz, Józef Dulak, František Šmíd, Libor Vítek, Lucie Muchová

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Drug-Repurposing Strategy for Dimethyl Fumarate.Pharmaceuticals (Basel, Switzerland) · 2023
    Article
  5. Article
  6. Gangliosides and Neuroblastomas.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Václav ŠmídInstitute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine and General University Hospital in Prague, Charles University, Katerinska 32, 12108 Prague, Czech Republic.ORCID 0000-0002-8664-7918
Jakub ŠukInstitute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine and General University Hospital in Prague, Charles University, Katerinska 32, 12108 Prague, Czech Republic.ORCID 0000-0001-6786-0716
Neli Kachamakova-TrojanowskaDepartment of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 7 Gronostajowa St., 30-387 Krakow, Poland.
Jana JašprováInstitute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine and General University Hospital in Prague, Charles University, Katerinska 32, 12108 Prague, Czech Republic.
Petra ValáškováInstitute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine and General University Hospital in Prague, Charles University, Katerinska 32, 12108 Prague, Czech Republic.ORCID 0000-0002-8673-1423
Alicja JózkowiczDepartment of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 7 Gronostajowa St., 30-387 Krakow, Poland.ORCID 0000-0002-7317-260X
Józef DulakDepartment of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 7 Gronostajowa St., 30-387 Krakow, Poland.
František ŠmídInstitute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine and General University Hospital in Prague, Charles University, Katerinska 32, 12108 Prague, Czech Republic.
Libor VítekInstitute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine and General University Hospital in Prague, Charles University, Katerinska 32, 12108 Prague, Czech Republic.ORCID 0000-0002-5318-0151
Lucie MuchováInstitute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine and General University Hospital in Prague, Charles University, Katerinska 32, 12108 Prague, Czech Republic.ORCID 0000-0003-2082-1060
Charles University · CZJagiellonian University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heme oxygenase 1 (Hmox1), a ubiquitous enzyme degrading heme to carbon monoxide, iron, and biliverdin, is one of the cytoprotective enzymes induced in response to a variety of stimuli, including cellular oxidative stress. Gangliosides, sialic acid-containing glycosphingolipids expressed in all cells, are involved in cell recognition, signalling, and membrane stabilization. Their expression is often altered under many pathological and physiological conditions including cell death, proliferation, and differentiation. The aim of this study was to assess the possible role of Hmox1 in ganglioside metabolism in relation to oxidative stress. The content of liver and brain gangliosides, their cellular distribution, and mRNA as well as protein expression of key glycosyltransferases were determined in

Indexed as

AnimalsBrainCell Line, TumorGangliosidesHeme Oxygenase-1HumansLiverMiceMice, KnockoutOxidative StressSignal TransductionGangliosidesHeme Oxygenase-1

Identifiers

PMID30327713
PMCPMC6169227
OpenAlexW2890792603

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.